Xu Jian (绪健)绪健
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 海南斯达制药有限公司Chinese legal name: 海南斯达制药有限公司
主要成分Active Ingredients
- 二乙酰氨乙酸乙二胺Eryi Xianan Yisuan Yier An
药物知识说明
二乙酰氨乙酸乙二胺是一种在国家药监局注册认定的药品。该药品含有二乙酰氨乙酸乙二胺-5a8e2d32等成分。
该药品关联的活性成分包括：二乙酰氨乙酸乙二胺Eryi Xianan Yisuan Yier An。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：海南斯达制药有限公司Chinese legal name: 海南斯达制药有限公司。
您可以探索含有相同成分的其他药品：二乙酰氨乙酸乙二胺-5a8e2d32成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 绪健) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 二乙酰氨乙酸乙二胺Eryi Xianan Yisuan Yier An.
Manufacturers recorded for this product: 海南斯达制药有限公司Chinese legal name: 海南斯达制药有限公司.
Explore other medicines containing the same ingredient: 二乙酰氨乙酸乙二胺 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 绪健Recorded Chinese name: 绪健
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 0.3g0.3 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 海南斯达制药有限公司Chinese legal name: 海南斯达制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20050607
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20050607
Manufacturer
Chinese legal name: 海南斯达制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20050607
生产企业
海南斯达制药有限公司(国产)
适应症
本品适用于预防和治疗各种原因出血。对手术渗血、外科出血、呼吸道出血、五官出血、妇科出血、痔疮出血、泌尿道出血、癌出血、消化道出血、颅脑出血等均有较好疗效。
用法用量
1.静脉注射，静脉滴注或肌内注射，凡遇急救性情况，第一次可大剂量静脉注射和静脉滴注同时应用。 2.静脉滴注：常用量每次0.6g（0.3g、2瓶）或遵医嘱，每日最高限量为1.2g(0.3g、4瓶/0.4g、3瓶)，以5%葡萄糖液250～500ml稀释后使用。
不良反应
可能出现的不良反应有头昏、心率减慢、乏力、皮肤麻木、发热感，口干、呕吐、恶心等。大多能自行消失或停药后能消失。
禁忌
对本品或含本品药物过敏者禁用。
注意事项
1.使用本品期间，如出现不良事件和/或不良反应，请咨询医生。2.同时使用其他药品，请告知医生。3.请放置于儿童不能触及的地方。
贮藏
密封，在阴凉处保存。
规格
0.3g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.